ZA202000609B - Novel composition of enzalutamide oral dosage form and method of manufacturing thereof - Google Patents

Novel composition of enzalutamide oral dosage form and method of manufacturing thereof

Info

Publication number
ZA202000609B
ZA202000609B ZA2020/00609A ZA202000609A ZA202000609B ZA 202000609 B ZA202000609 B ZA 202000609B ZA 2020/00609 A ZA2020/00609 A ZA 2020/00609A ZA 202000609 A ZA202000609 A ZA 202000609A ZA 202000609 B ZA202000609 B ZA 202000609B
Authority
ZA
South Africa
Prior art keywords
enzalutamide
manufacturing
dosage form
oral dosage
novel composition
Prior art date
Application number
ZA2020/00609A
Inventor
Dharmesh Mahendrabhai Shah
Aravind Manappa Badiger
Rakshit Ketanbhai Choksi
Bhavesh Naginbhai Patel
Piyusha Sharad Salunkhe
Niraj Ramnivedan Soni
Original Assignee
Bdr Pharmaceuticals International Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=64950639&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA202000609(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bdr Pharmaceuticals International Private Ltd filed Critical Bdr Pharmaceuticals International Private Ltd
Publication of ZA202000609B publication Critical patent/ZA202000609B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2020/00609A 2017-07-04 2020-01-29 Novel composition of enzalutamide oral dosage form and method of manufacturing thereof ZA202000609B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201721023465 2017-07-04
PCT/IB2017/057273 WO2019008426A1 (en) 2017-07-04 2017-11-21 Novel composition of enzalutamide oral dosage form and method of manufacturing thereof

Publications (1)

Publication Number Publication Date
ZA202000609B true ZA202000609B (en) 2021-08-25

Family

ID=64950639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2020/00609A ZA202000609B (en) 2017-07-04 2020-01-29 Novel composition of enzalutamide oral dosage form and method of manufacturing thereof

Country Status (7)

Country Link
BR (1) BR112020000207A2 (en)
CL (1) CL2020000017A1 (en)
MX (1) MX2020000213A (en)
PH (1) PH12020500045A1 (en)
RU (1) RU2020105102A (en)
WO (1) WO2019008426A1 (en)
ZA (1) ZA202000609B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR118925A1 (en) * 2020-05-13 2021-11-10 Novocap S A CONCENTRATED LIQUID SOLUTION OF NON-STEROID ANTIANDROGENS AND PROCEDURE FOR PREPARING THE SOLUTION
WO2023281528A1 (en) 2021-07-07 2023-01-12 Bdr Pharmaceuticals Int’L Pvt. Ltd "novel oral liquid compositions of enzalutamide and method of manufacturing thereof"

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2940984A1 (en) * 2014-02-05 2015-08-13 Lek Pharmaceuticals D.D. Solid pharmaceutical compositions of androgen receptor antagonists
IN2015CH04824A (en) * 2015-09-10 2017-03-17

Also Published As

Publication number Publication date
CL2020000017A1 (en) 2020-05-22
RU2020105102A (en) 2021-08-04
PH12020500045A1 (en) 2020-11-09
WO2019008426A1 (en) 2019-01-10
MX2020000213A (en) 2020-08-17
BR112020000207A2 (en) 2020-07-07

Similar Documents

Publication Publication Date Title
ZA201704976B (en) Oral care compositions and methods of use
ZA201708429B (en) Oral solid formulation containing irinotecan and method of preparing the same
IL273259A (en) Manufacturing of pharmaceutical compositions
ZA202004531B (en) Compositions containing thymohydroquinone and their method of preparation
ZA201703763B (en) Oral care composition and method of use
ZA201807476B (en) Oral care composition and method of use
PL3661508T3 (en) Manufacturing method of oral dosage form containing berberine, oral dosage form containing berberine and use thereof
ZA201801015B (en) Oral care compositions and methods of using the compositions
IL250852A0 (en) Periodontal composition and method of use
ZA202000609B (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
GB201708500D0 (en) Oral care composition, process for preparation and method of use thereof
PL3643325T3 (en) A composition comprising furazidin and a method of its manufacturing
SI3277266T1 (en) Oral solid dosage form of amlodipine and veterinary uses thereof
GB201718475D0 (en) Pharmaceutical composition for treatment of depression and preparation method thereof
PT3665183T (en) Method of manufacturing a pharmaceutical composition
IL258304B (en) Oral care compositions and methods of using the compositions
IL273904A (en) Pharmaceutical resinate compositions and methods of making and using thereof
PL3668326T3 (en) Chewing gum compositions and methods of making thereof
PL3634143T3 (en) Chewing gum compositions and methods of making thereof
ZA202101538B (en) Novel composition of lapatinib of oral solid dosage form and method of manufacturing thereof
GB201501413D0 (en) A confectionery composition and a method of manufacturing thereof
GB201719915D0 (en) A composition and method of preparation thereof
GB201703964D0 (en) Composition and method of manufacture
GB201701014D0 (en) Composition and method of production thereof
GB201805578D0 (en) Prebiotic compositions and methods of production thereof